The TBVI consortium receives funding from the European Commission, government agencies, private foundations and industry. Over the past seven years, a total of €46.5 million has been received to support ongoing and anticipated activities until 2017. These activities include R&D activities and the services that TBVI provides to the consortium partners (see Figure 1).

Figure 1: Donations and pledges 2010-2017 (in € x 1000)

Print

Figure 2 shows the allocation of these funds to R&D activities (broken down into 5 strategic areas) and to TBVI services and administration.

Figure 2: Allocation of funding to strategic areas

Print
Reporting standards

As a Dutch non-profit foundation, TBVI meets the criteria set for ‘Algemeen Nut Beogende Instellingen’ (ANBI), or Public Benefit Organisations, which are applicable for charity fundraising. TBVI works according to the applicable audit standard RJ 650 (RvJ). Auditing of TBVI accounts is conducted annually by PricewaterhouseCoopers Accountants NV.  For more information, please contact Anne Meinema.

Financial report 2016

STICHTING TUBERCULOSIS VACCINE INITIATIVE (TBVI)  RSIN 819122452  VAT no. NL8191.22.452.B.01